American Journal of Hematology · 2009 · 77 citations · 18 references
MedicineChild HealthPediatricsPediatric HematologyPediatric PulmonologyPulmonologyCorticosteroid TherapyPediatric Acute CareReadmission AnalysisReadmission PreventionAcute Chest SyndromeComorbid Asthma ManagementInhaled Corticosteroid AdministrationPediatric Corticosteroid TherapyPediatric ReadmissionsPropensity Score AdjustmentReadmission Rate AnalysisReadmission Rates
Acute chest syndrome (ACS) causes significant morbidity and mortality in sickle cell disease. The role of corticosteroids is unclear. The objectives of our study were to examine the variation between hospitals in their use of corticosteroids for ACS, describe characteristics associated with corticosteroids, and investigate the association between corticosteroids, length of stay, and readmission. We performed a retrospective examination of 5,247 hospitalizations for ACS between January 1, 2004, and June 30, 2008, at 32 hospitals in the Pediatric Health Information System database. We used multivariate regression to examine the variability in the use of corticosteroids adjusting for hospital case mix, identify factors associated with corticosteroid use, and evaluate the association of corticosteroids with length of stay and 3-day readmission rates controlling for propensity score. Corticosteroid use varied greatly by hospital (10-86% among all patients, 18-92% in patients with asthma). Treatment with corticosteroids was associated with comorbid asthma (OR 3.9, 95% CI: 3.2-4.8), inhaled steroids (OR 1.4, 95% CI: 1.1-1.7), bronchodilators (OR 3.2, 95% CI: 2.5-4.2), nitric oxide (OR 2.4, 95% CI: 1.2-5.0), oxygen (OR 2.3, 95% CI: 1.8-2.9), ICU (OR 1.7, 95% CI: 1.3-2.3), ventilation (OR 2.0, 95% CI: 1.4-2.8), APR-DRG severity level (OR 1.4, 95% CI: 1.2-1.6), and discharge year (OR 0.86, 95% CI: 0.80-0.92). Corticosteroids were associated with an increased length of stay (25%, 95% CI: 14-38%) and a higher 3-day readmission rate (OR 2.3, 95% CI: 1.6-3.4), adjusted for confounding. Hospitals vary greatly in the use of corticosteroids for ACS, even in patients with asthma. Clear evidence of the efficacy and toxicity of corticosteroid treatment in ACS may reduce variation in care.
18
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Elliott Vichinsky, Lynne Neumayr, Ann N. Earles et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text
Medicine, Cardiology, Hematology +7
Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral Head
Paul Milner, Alfred Kraus, Jeno Sebes et al. · New England Journal of Medicine · 1991 · 378 citations · Full text
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia
Elliott Vichinsky, R Williams, M Das et al. · Blood · 1994 · 255 citations · Full text
Medicine, Cardiology, Hematology +11
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia
Jessica H. Boyd, Eric A. Macklin, Robert C. Strunk et al. · Blood · 2006 · 253 citations · Full text
Medicine, Hematology, Pediatrics +12